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Cardiac resynchronisation therapy (CRT) is an
effective treatment for patients with advanced heart
failure (HF), New York Heart Association class
(NYHA) III or IV, a reduced left ventricular ejection
fraction (LVEF \35%), and wide QRS complexes
([120 ms) [1, 2]. The beneﬁcial effects include
improvement in HF symptoms, exercise capacity, and
LV function, as well as less HF hospitalizations and
lower mortality rates. Despite these impressive
results around 30% of patients show no beneﬁt after
CRT, being the so-called ‘non-responders’ [3–5]. The
presence of LV dyssynchrony prior to implantation
and its subsequent reduction after implantation are
proposed the key mechanism for response to CRT.
Initially, QRS duration was used as a marker of LV
dyssynchrony. Recently, various studies have dem-
onstrated that patients with extensive baseline LV
dyssynchrony have a high likelihood of responding
after CRT implantation, whereas patients without
baseline LV dyssynchrony fail to beneﬁt [6–8].
A variety of techniques has been proposed to
quantify LV dyssynchrony in HF patients, ranging
from simple M-mode echocardiography to more
sophisticated techniques such as tissue Doppler
imaging (TDI), real time three-dimensional echocar-
diography (RT3DE), and strain imaging techniques
including speckle tracking [9]. Recent research using
advanced echocardiographic modalities have pro-
vided new insight on the proper patient selection, lead
implantation, optimization and reasons for non-
response [10, 11].
In the current issue of the International Journal of
Cardiovascular Imaging, Pavlopoulos and Nihoyan-
nopoulos [12] discuss the recent advances of echocar-
diography in the evaluation of patients eligible for
CRT. The authors nicely describe the various param-
eters that can be used for optimal patient selection and
for evaluation of the response to therapy. Advanced
echocardiographic modalities do provide new insights
on proper patient selection, lead implantation, optimi-
zation and reasons for non-response. Several echo-
cardiographic parameters can be used in order to
deﬁne the acute or long-term CRT responses. These
parameters are changes in LVEF C15%, reverse LV
remodeling (LV end-systolic dimensions/volumes
C15%); degree of mitral regurgitation, dp/dt, and
cardiac output. Interestingly, the authors point out that
overall assessment of echocardiographic parameters
appears to contribute signiﬁcantly to the outcome of
CRT beyond electrical or mechanical dyssynchrony.
In addition to the described echocardiographic
parameters, several non-echocardiographic imaging
techniques such as magnetic resonance imaging
(MRI), nuclear imaging, and computed tomography
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with LV dyssynchrony. The use of MRI has been
proven for patients with a variety of cardiac diseases
[13–20] and is rapidly expanding for selecting
patients for CRT [21–24]. Cardiac MRI does not
only provide information on size, shape and function
of the LV (which is of interest in patients with a
suboptimal acoustic window), but also on LV
dyssynchrony. In particular the identiﬁcation of scar
tissue is of paramount interest in patients eligible for
CRT in selecting the optimal positioning of the
pacing lead. Westenberg et al. [23] compared LV
dyssynchrony assessed by TDI with LV dyssynchro-
ny assessed by velocity-encoded MRI in 20 HF
patients and found an excellent agreement between
both modalities (r = 0.97, P\0.01). With contrast-
enhancement MRI accurate visualization of scar
tissue was possible. Bleeker et al. [24] applied this
technique in 40 patients with ischemic HF and
investigated the relationship between response to
CRT and the presence of scar tissue in the postero-
lateral wall, being the preferred region for the LV
pacing lead. After 6 months of CRT, 21 of the 26
(81%) patients without transmural scar tissue in the
posterolateral region responded to CRT compared
with only two of the 14 (14%) patients with
transmural scar tissue in the posterolateral area
(P\0.01). Moreover, patients with transmural pos-
terolateral scarring exhibited no signiﬁcant reduction
in LV dyssynchrony the day after CRT implantation,
suggesting absence of LV resynchronization, thereby
explaining the lack of response.
Similar to MRI, nuclear imaging is well suited for
the assessment of viability, scar tissue [25–31], and
LV dyssynchrony [32–35]. Only a few studies used
radionuclide angiography with phase image analysis
for the assessment of LV and interventricular dys-
synchrony in CRT candidates [35, 36]. However,
these studies demonstrate greatest beneﬁt of CRT in
patients with LV rather than interventricular dyssyn-
chrony. This ﬁnding is in contrast with larger TDI
studies, and further studies including comparisons
with TDI are therefore required. Recent studies
showed that gated SPECT imaging can be used for
the assessment of LV dyssynchrony [37, 38]. Henn-
eman et al. [37] analyzed four quantitative indices of
phase analysis in 75 HF patients and compared them
with conventional TDI. The variables histogram
bandwidth and phase standard deviation showed a
good correlation with TDI. In addition, cut-off values
of 135 for histogram bandwidth and 43 for phase
standard deviation were proposed to predict an
improvement in NYHA class after CRT. In addition,
nuclear imaging is well suited for assessment of
viability and scar tissue. Sciagra et al. [38] were the
ﬁrst to demonstrate that patients with severe resting
defects at 99mTc-sestamibi SPECT imaging at base-
line showed lack of response after CRT.
Computed tomography (CT) techniques can not
yet be used to determine LV dyssynchrony itself, but
CT does allow noninvasive visualization of the
coronary anatomy and the coronary venous system
[39–52]. Van de Veire et al. [53] investigated the
cardiac venous anatomy in 34 patients with a
previous myocardial infarction, 38 patients with
signiﬁcant coronary artery disease and 28 control
patients using a 64-slice MSCT. The coronary sinus,
anterior interventricular vein, and posterior interven-
tricular vein could be visualized in nearly all these
patients. However, in patients with a history of
myocardial infarction, the left marginal vein was
detected signiﬁcantly less often (27%). At present,
MSCT is not routinely used prior to CRT implanta-
tion, mainly because of the radiation dose and lack of
information on LV dyssynchrony and site of latest
activation [54]. However, these ﬁndings suggest that
patients with previous infarction may have less
suitable venous anatomy for LV lead placement,
and surgical (epicardial) LV lead positioning may be
considered.
To summarize, several noninvasive imaging
modalities have been proposed for the quantiﬁcation
of LV dyssynchrony but there is currently no
agreement on which technique best predicts response
to CRT. For now, most experience is gained with
echocardiographic TDI and it remains the technique
of choice, as also mentioned by Pavlopoulos and
Nihoyannopoulos [12]. Major consensus is ‘the more
LV dyssynchrony prior to implantation, the higher
the likelihood of signiﬁcant LV reverse remodeling
during follow-up’. At present, substantial evidence is
growing for non-echocardiographic imaging methods
to assess LV dyssynchrony such as MRI, nuclear
imaging and CT. These techniques may provide
valuable additional information that is potentially
important for the selection of CRT candidates.
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